Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Oncogene|December 8, 2004
HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencingTai-On Yau, Chung-Yiu Chan, Kok-Lung Chan, et al.
Plos One|February 25, 2011
Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recoveryChun-Ming Wong, Carmen Chak-Lui Wong, Yeung-Lam Ng, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasisChun-Ming Wong, Carmen Chak-Lui Wong, Joyce Man-Fong Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2005
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activityThomas Ho-Yin Leung, Yick-Pang Ching, Judy Wai Ping Yam, et al.
The Journal of Biological Chemistry|January 18, 2003
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinomaYick-Pang Ching, Chun-Ming Wong, Shing-Fai Chan, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 9, 2022
In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular CarcinomaLok-Sze Wong, Lai Wei, Gengchao Wang, et al.
Cancer Research|October 6, 2005
Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinomaChun-Ming Wong, Judy Wai-Ping Yam, Yick-Pang Ching, et al.
Plos One|July 24, 2008
Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinomaCarmen Chak-Lui Wong, Chun-Ming Wong, Frankie Chi-Fat Ko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 31, 2009
Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinomaFrankie Chi Fat Ko, Yin-Shan Yeung, Chun-Ming Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancerFor-Fan Chan, Kenneth Kin-Leung Kwan, Do-Hyun Seoung, et al.
Pageof 10